EX-99 2 ex-99.htm EX-99

Exhibit 99

 

Form 4 Joint Filer Information

 

Name:

Mark Lappe

 

 

Address:

11622 El Camino Real, Suite 100
San Diego, CA 92130

 

 

Designated Filer:

Efficacy Capital Ltd.

 

 

Issuer & Ticker Symbol:

Repros Therapeutics Inc. (RPRX)

 

 

Date of Event
Requiring Statement:

3/14/2008

 

 

Signature

s/ Mark Lappe

 

 

 

Name:

Jon Faiz Kayyem

 

 

Address:

11622 El Camino Real, Suite 100
San Diego, CA 92130

 

 

Designated Filer:

Efficacy Capital Ltd.

 

 

Issuer & Ticker Symbol:

Repros Therapeutics Inc. (RPRX)

 

 

Date of Event
Requiring Statement:

3/14/2008

 

 

Signature

s/ Jon Faiz Kayyem

 

 



 

Name:

Efficacy Capital Ltd.

 

 

Address:

11622 El Camino Real, Suite 100
San Diego, CA 92130

 

 

Designated Filer:

Efficacy Capital Ltd.

 

 

Issuer & Ticker Symbol:

Repros Therapeutics Inc. (RPRX)

 

 

Date of Event
Requiring Statement:

3/14/2008

 

 

Signature

Efficacy Capital Ltd.

 

 

 

By:

s/ Mark Lappe

 

 

Managing Partner

 

 

Name:

Efficacy Biotech Fund L.P.

 

 

Address:

11622 El Camino Real, Suite 100
San Diego, CA 92130

 

 

Designated Filer:

Efficacy Capital Ltd.

 

 

Issuer & Ticker Symbol:

Repros Therapeutics Inc. (RPRX)

 

 

Date of Event
Requiring Statement:

3/14/2008

 

 

Signature

Efficacy Capital Ltd., Investment Manager

 

 

 

By:

s/ Mark Lappe

 

 

Managing Partner

 



 

Name:

Efficacy Biotech Fund Limited

 

 

Address:

11622 El Camino Real, Suite 100
San Diego, CA 92130

 

 

Designated Filer:

Efficacy Capital Ltd.

 

 

Issuer & Ticker Symbol:

Repros Therapeutics Inc. (RPRX)

 

 

Date of Event
Requiring Statement:

3/14/2008

 

 

Signature

Efficacy Capital Ltd., Investment Manager

 

 

 

By:

s/ Mark Lappe

 

 

Managing Partner

 



 

Name:

Efficacy Biotech Master Fund Ltd.

 

 

Address:

11622 El Camino Real, Suite 100
San Diego, CA 92130

 

 

Designated Filer:

Efficacy Capital Ltd.

 

 

Issuer & Ticker Symbol:

Repros Therapeutics Inc. (RPRX)

 

 

Date of Event
Requiring Statement:

3/14/2008

 

 

Signature

Efficacy Capital Ltd., Investment Manager

 

 

 

By:

s/ Mark Lappe

 

 

Managing Partner